No Data
No Data
Genmab A/S Plans Strategic Capital Expansion by 2029
6-K: Report of foreign private issuer (related to financial reporting)
Top Gap Ups and Downs on Monday: SMCI, ZM, GFI and More
Express News | Corrected-Buzz-U.S. Stocks on the Move-AMC, Alnylam, Super Micro
Genmab to Present at Citi's Global Healthcare Conference
Jefferies Sticks to Their Hold Rating for Genmab A/S (0MGB)
No Data
No Data